Your browser doesn't support javascript.
loading
Polymorphisms in the Von Hippel-Lindau Gene Are Associated With Overall Survival in Metastatic Clear-Cell Renal-Cell Carcinoma Patients Treated With VEGFR Tyrosine Kinase Inhibitors.
Verbiest, Annelies; Lambrechts, Diether; Van Brussel, Thomas; Couchy, Gabrielle; Wozniak, Agnieszka; Méjean, Arnaud; Lerut, Evelyne; Oudard, Stéphane; Verkarre, Virginie; Job, Sylvie; de Reynies, Aurélien; Machiels, Jean-Pascal; Patard, Jean-Jacques; Zucman-Rossi, Jessica; Beuselinck, Benoit.
Afiliação
  • Verbiest A; Laboratory of Experimental Oncology, Department of Oncology, University of Leuven, Leuven, Belgium; Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.
  • Lambrechts D; Center for Cancer Biology, Flemish Institute for Biotechnology, Leuven, Belgium; Laboratory for Translational Genetics, Department of Human Genetics, University of Leuven, Leuven, Belgium.
  • Van Brussel T; Center for Cancer Biology, Flemish Institute for Biotechnology, Leuven, Belgium; Laboratory for Translational Genetics, Department of Human Genetics, University of Leuven, Leuven, Belgium.
  • Couchy G; INSERM, UMR-1162, Functional Genomics of Solid Tumors, Institute of Hematology, Paris, France.
  • Wozniak A; Laboratory of Experimental Oncology, Department of Oncology, University of Leuven, Leuven, Belgium.
  • Méjean A; Department of Urology, University Hospitalsof Central Paris, Paris, France.
  • Lerut E; Department of Pathology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.
  • Oudard S; Department of Medical Oncology, University Hospitalsof Central Paris, Paris, France.
  • Verkarre V; Department of Pathology, University Hospitalsof Central Paris, Paris, France.
  • Job S; Programme Cartes d'Identité des Tumeurs, Ligue Nationale Contre le Cancer, Paris, France.
  • de Reynies A; Programme Cartes d'Identité des Tumeurs, Ligue Nationale Contre le Cancer, Paris, France.
  • Machiels JP; Institut Roi Albert II, Service d'Oncologie Médicale, Cliniques universitaires Saint-Luc and Institut de Recherche Clinique et Expérimentale, Université Catholique de Louvain, Brussels, Belgium.
  • Patard JJ; Department of Urology, Hôpital Bicêtre, Paris, France.
  • Zucman-Rossi J; INSERM, UMR-1162, Functional Genomics of Solid Tumors, Institute of Hematology, Paris, France.
  • Beuselinck B; Laboratory of Experimental Oncology, Department of Oncology, University of Leuven, Leuven, Belgium; Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium. Electronic address: benoit.beuselinck@uzleuven.be.
Clin Genitourin Cancer ; 16(4): 266-273, 2018 08.
Article em En | MEDLINE | ID: mdl-29503246
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Polimorfismo de Nucleotídeo Único / Inibidores de Proteínas Quinases / Proteína Supressora de Tumor Von Hippel-Lindau / Neoplasias Renais Tipo de estudo: Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Polimorfismo de Nucleotídeo Único / Inibidores de Proteínas Quinases / Proteína Supressora de Tumor Von Hippel-Lindau / Neoplasias Renais Tipo de estudo: Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article